Your browser is no longer supported. Please, upgrade your browser.
Settings
NDRA ENDRA Life Sciences Inc. daily Stock Chart
NDRA [NASD]
ENDRA Life Sciences Inc.
Index- P/E- EPS (ttm)-1.92 Insider Own3.30% Shs Outstand7.40M Perf Week-3.31%
Market Cap10.80M Forward P/E- EPS next Y-1.21 Insider Trans- Shs Float7.12M Perf Month-9.88%
Income-9.70M PEG- EPS next Q-0.31 Inst Own17.00% Short Float10.55% Perf Quarter-4.57%
Sales0.00M P/S- EPS this Y-11.50% Inst Trans- Short Ratio5.62 Perf Half Y-21.51%
Book/sh0.51 P/B2.86 EPS next Y2.40% ROA-240.00% Target Price5.56 Perf Year-30.14%
Cash/sh0.53 P/C2.77 EPS next 5Y- ROE-337.10% 52W Range0.90 - 5.75 Perf YTD-2.67%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-74.61% Beta-
Dividend %- Quick Ratio5.20 Sales past 5Y- Gross Margin- 52W Low62.24% ATR0.17
Employees5 Current Ratio5.20 Sales Q/Q- Oper. Margin- RSI (14)46.59 Volatility8.75% 11.38%
OptionableNo Debt/Eq0.00 EPS Q/Q48.60% Profit Margin- Rel Volume0.14 Prev Close1.46
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume133.74K Price1.46
Recom1.70 SMA20-9.83% SMA503.38% SMA200-34.37% Volume8,682 Change0.00%
Jul-22-19 08:31AM  ENDRA Life Sciences to Host Second Quarter 2019 Results Conference Call on Thursday, August 8, 2019 at 4:30 p.m. ET ACCESSWIRE
Jul-04-19 11:45AM  What Kind Of Investor Owns Most Of ENDRA Life Sciences Inc. (NASDAQ:NDRA)? Simply Wall St.
Jul-01-19 08:31AM  ENDRA Life Sciences and Rocky Vista University College of Osteopathic Medicine Partnering for Clinical Study of Thermo Acoustic Enhanced Ultrasound Device ACCESSWIRE
Jun-24-19 08:31AM  ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the 2nd International Conference on Fatty Liver (ICFL 2019) ACCESSWIRE
Jun-03-19 08:31AM  ENDRA Life Sciences Appoints Renaud Maloberti as Chief Commercial Officer ACCESSWIRE
May-14-19 04:01PM  ENDRA Life Sciences Reports First Quarter 2019 Financial & Operational Results ACCESSWIRE
Apr-24-19 08:31AM  ENDRA Life Sciences to Host First Quarter 2019 Results Conference Call on Tuesday, May 14, 2019 at 4:30 p.m. ET ACCESSWIRE
Apr-17-19 08:31AM  ENDRA Life Sciences Granted U.S. Patent for Determining Fractional Fat Content of Tissue ACCESSWIRE
Apr-03-19 08:31AM  ENDRA Life Sciences Receives ISO 13485 Certification ACCESSWIRE
Mar-29-19 08:31AM  ENDRA Life Sciences Reports Initial Findings on First Human TAEUS Feasibility Study of Liver Fat ACCESSWIRE -41.55%
Mar-11-19 04:01PM  ENDRA Life Sciences Reports Full Year 2018 Financial & Operational Results ACCESSWIRE
Feb-22-19 08:31AM  ENDRA Life Sciences to Host Fourth Quarter and Full Year 2018 Results Conference Call on Monday, March 11, 2019 at 4:30 p.m. ET ACCESSWIRE
Jan-22-19 08:31AM  ENDRA Life Sciences Announces Artificial Intelligence Initiative ACCESSWIRE -7.53%
Jan-02-19 07:31AM  ENDRA Life Sciences Issues Shareholder Letter ACCESSWIRE +16.67%
Dec-17-18 07:31AM  ENDRA Life Sciences Provides Update on First Human Study ACCESSWIRE -5.61%
Dec-03-18 01:00PM  ENDRA Life Sciences to Present at the 11th Annual LD Micro Main Event on December 5, 2018 ACCESSWIRE -6.65%
Nov-26-18 07:31AM  ENDRA Life Sciences to Present at Upcoming Investor Conferences ACCESSWIRE
Nov-14-18 08:10AM  Report: Exploring Fundamental Drivers Behind Targa Resources, IntriCon, ENDRA Life Sciences, Coffee Holding Co., Orion Group, and Carbon Black New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-13-18 03:01PM  ENDRA Life Sciences Announces Closing of Public Offering and Exercise of Over-Allotment Option ACCESSWIRE
Nov-08-18 07:31AM  ENDRA Life Sciences Prices Public Offering of Common Stock ACCESSWIRE
Nov-07-18 03:01PM  ENDRA Life Sciences Announces Proposed Public Offering of Common Stock ACCESSWIRE
Nov-05-18 03:01PM  ENDRA Life Sciences Reports Third Quarter 2018 Financial Results ACCESSWIRE
Oct-29-18 10:44AM  My Stock of the Week: ENDRA Life Sciences TheStreet.com
Oct-24-18 08:31AM  ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at Three Global Liver and Imaging Conferences in November 2018 ACCESSWIRE -13.20%
Oct-23-18 08:31AM  ENDRA Life Sciences to Host Third Quarter 2018 Results Conference Call on Monday, November 5, 2018 at 4:30 p.m. ET ACCESSWIRE
Oct-16-18 08:31AM  ENDRA Life Sciences Receives Approval to Initiate Human Studies of its TAEUS(TM) Device Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE +12.35%
Oct-15-18 04:01PM  ENDRA Life Sciences Announces Closing of Public Offering and Exercise of Over-Allotment Option ACCESSWIRE
Oct-11-18 08:50AM  ENDRA Life Sciences Inc. Prices Public Offering of Common Stock ACCESSWIRE -11.76%
07:39AM  The Daily Biotech Pulse: Clinical Hold Lifted Off Crispr's Gene-Edited Therapy, Endra To Offer Shares Benzinga
Oct-10-18 04:10PM  ENDRA Life Sciences Inc. Announces Proposed Public Offering of Common Stock ACCESSWIRE -9.57%
Aug-29-18 08:31AM  ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the EASL Non-Alcoholic Fatty Liver Disease Summit in Geneva Switzerland on September 20-22, 2018 ACCESSWIRE
Aug-13-18 04:01PM  ENDRA Life Sciences Reports Second Quarter 2018 Financial Results ACCESSWIRE
Jul-31-18 08:31AM  ENDRA Life Sciences Granted Two U.S. Patents For Correcting Fat-Induced Aberrations & Imaging Biological Tissue Structures ACCESSWIRE
Jul-25-18 08:31AM  ENDRA Life Sciences to Host Second Quarter 2018 Results Conference Call on Monday, August 13, 2018 at 4:30 p.m. ET ACCESSWIRE -6.51%
Jul-12-18 08:31AM  ENDRA Life Sciences Granted U.S. Patent for Magnetic Resonance Imaging (MRI) Safety Based on TAEUS Technology ACCESSWIRE
Jul-02-18 08:31AM  ENDRA Life Sciences Completes Private Placement of $1.1 Million of Convertible Secured Notes and Warrants ACCESSWIRE
Jun-05-18 08:30AM  ENDRA Life Sciences Granted Third U.S. Patent for Non-Invasive Fat Assessment to Support TAEU(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE +11.67%
May-24-18 04:19PM  Should You Worry About ENDRA Life Sciences Incs (NASDAQ:NDRA) CEO Pay Check? Simply Wall St.
May-15-18 04:01PM  ENDRA Life Sciences Reports First Quarter 2018 Financial Results ACCESSWIRE -15.52%
Apr-26-18 08:31AM  ENDRA Life Sciences to Host First Quarter 2018 Results Conference Call on Tuesday, May 15, 2018 at 4:30 p.m. ET ACCESSWIRE
Apr-09-18 08:31AM  ENDRA Life Sciences to Showcase Photoacoustic Imaging Technology at American Association for Cancer Research (AACR) Annual Meeting on April 14-18 in Chicago ACCESSWIRE +10.38%
Apr-02-18 10:30AM  ENDRA Life Sciences to Present at The MicroCap Conference on Tuesday, April 10, 2018 ACCESSWIRE
Mar-20-18 04:01PM  ENDRA Life Sciences Reports Fourth Quarter and Full Year 2017 Financial Results ACCESSWIRE
Mar-08-18 12:59PM  ENDRA Life Sciences Inc (NASDAQ:NDRA): Does The -48.17% Earnings Decline Make It An Underperformer? Simply Wall St.
Mar-07-18 08:31AM  ENDRA Life Sciences to Host Fourth Quarter and Full Year 2017 Results Conference Call on Tuesday, March 20, 2018 at 4:30 p.m. ET ACCESSWIRE
Feb-27-18 08:31AM  ENDRA Life Sciences to Present at the Inaugural LD Micro Virtual Conference on Tuesday, March 6, 2018 at 5:00 p.m. ET ACCESSWIRE
Feb-15-18 08:31AM  ENDRA Life Sciences Granted Two U.S. Patents for Non-Invasive Fat Assessment to Support TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE +6.13%
Feb-05-18 08:31AM  ENDRA Life Sciences Renews and Extends Term of Collaboration Agreement with GE Healthcare to Develop ENDRA's TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE
Dec-27-17 05:25PM  Who Are The Top Investors In ENDRA Life Sciences Inc (NASDAQ:NDRA)? Simply Wall St.
Dec-08-17 06:33PM  What Did ENDRA Life Sciences Incs (NDRA) CEO Take Home Last Year? Simply Wall St. -7.94%
Nov-30-17 03:45PM  How ENDRA Life Sciences Incs (NDRA) EPS Dropped 45.2%, Did Its Industry Show Weakness Too? Simply Wall St.
Nov-22-17 08:31AM  ENDRA Life Sciences to Present at the 10th Annual LD Micro Main Event on December 6, 2017 ACCESSWIRE +11.72%
Nov-15-17 08:31AM  ENDRA Life Sciences Reports Third Quarter 2017 Financial Results ACCESSWIRE
08:17AM  Should Your Next Investment In The Healthcare Industry Be In ENDRA Life Sciences Inc (NDRA)? Simply Wall St.
Nov-08-17 09:22AM  ENDRA Life Sciences Contracts The Centre for Imaging Technology Commercialization (CIMTEC) to Initiate Human Studies with ENDRA's Clinical TAEUS(TM) Device Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE
Nov-02-17 08:31AM  ENDRA Life Sciences Partners with StarFish Medical and CriTech Research to Commence Development of TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease ACCESSWIRE
Oct-23-17 08:31AM  ENDRA Life Sciences to Host Third Quarter 2017 Results Conference Call on Wednesday, November 15, 2017 at 4:30 p.m. ET ACCESSWIRE
Sep-28-17 08:31AM  ENDRA Life Sciences Completes Delivery and Installation of its Next Generation Nexus 128+ to Leading Research University in South Korea ACCESSWIRE
Sep-27-17 08:31AM  ENDRA Life Sciences to Participate at Upcoming Investor Conferences ACCESSWIRE
Sep-07-17 08:31AM  ENDRA Life Sciences to Participate at Upcoming Investor Conferences ACCESSWIRE -7.69%
Sep-06-17 08:31AM  ENDRA Life Sciences to Present New Photoacoustic Imaging Research at the 2017 World Molecular Imaging Congress on September 16, 2017 ACCESSWIRE
Aug-08-17 08:31AM  ENDRA Life Sciences Reports Second Quarter 2017 Financial Results ACCESSWIRE -11.14%
Jul-06-17 10:00AM  ENDRA Life Sciences Inc. (NASDAQ: NDRA) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire
ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound. It offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. It also offers Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. ENDRA Life Sciences Inc. has collaborative research agreement with General Electric Company. The company was incorporated in 2007 and is based in Ann Arbor, Michigan.